Jiutian Chemical Group Limited ( (SG:C8R) ) has shared an announcement.
Jiutian Chemical Group Limited reported a significant decline in revenue for the first quarter of 2025, with an 83% drop compared to the same period last year, due to weak demand and increased competition. Despite this, the company managed to reduce its net loss by 56% through effective cost control and streamlined operations, reflecting a strategic focus on long-term efficiency and competitiveness.
More about Jiutian Chemical Group Limited
Jiutian Chemical Group Limited operates in the chemical industry, focusing on the production of Dimethylformamide (DMF) and Methylamine. The company is currently navigating a challenging market environment characterized by sluggish demand and increased competition, particularly in China.
YTD Price Performance: -23.33%
Average Trading Volume: 3,310,147
Technical Sentiment Signal: Buy
Current Market Cap: S$45.73M
For an in-depth examination of C8R stock, go to TipRanks’ Stock Analysis page.